| 摘要 |
<p>The present application relates to a series of compounds, and pharmaceutical formulations thereof, of formula (A) which provide a method of inhibiting hyperlipidemia, especially hypercholesterolemia, and the pathological sequelae thereof, in mammals, including humans.</p> |
